SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for UNITEDHEALTH GROUP INC (UNH) (CIK 0000731766) (UNH) — Feb 28, 2017

UNITEDHEALTH GROUP INC (UNH) (CIK 0000731766)
Date: Feb. 28, 2017 · CIK: 0000731766 · Accession: 0000000000-17-006723

AI Filing Summary & Sentiment

File numbers found in text: 333-216153

Date
February 28, 2017
Author
/s/ Mary Beth Breslin for
Form
UPLOAD
Company
UNITEDHEALTH GROUP INC (UNH) (CIK 0000731766)

Letter

Mail Stop 4546 February 28, 2017 Marianne D. Short UnitedHealth Group Incorporated Executive Vice President and Chief Legal Officer UnitedHealth Group Center 9900 Bren Road East Minnetonka, Minnesota 55343

Re: UnitedHealth Group Incorporated Registration Statement on Form S-4 Filed February 21, 2017 File No. 333-216153

Dear Ms. Short :

We have limited our review of your registration statement to those issues we have addressed in our comment .

Please respond to this letter by amending your registration statement and providing the requested information . If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to this comment , we may have additional comments.

General

1. We note that your filing incorporates by reference the Annual Report on Form 10 -K for the fiscal year ended December 31, 2016. We also note that Part III of the Form 10 -K incorporate s by reference the proxy statement for the 2017 annual meeting of shareholders, which has not yet been filed. Please be advised that we will not be in a position to accelerate the effective date of your registration statement until the 10 -K is amended to include Part II I information, or the proxy statement is filed . For guidance, please refer generally to an analogous provision applicable to Form S -3 registrant s in Securities Act Forms Compliance and Disclosure Interpretation 123.01.

We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or a bsence of action by the staff.

Marianne D. Short UnitedHealth Group Incorporated February 28, 2017 Page 2

Refer to Rules 460 and 461 regarding requests for acceleration . Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement.

You may contact Chris Edwards at (202) 551 -6761 or Mary Beth Breslin at (202) 551 - 3625 with any questions.

Sincerely,
/s/ Mary Beth Breslin for

Show Raw Text
Mail Stop 4546
February 28, 2017

Marianne D. Short
UnitedHealth Group Incorporated
Executive Vice President and Chief Legal Officer
UnitedHealth Group Center
9900 Bren Road East
Minnetonka, Minnesota 55343

Re: UnitedHealth Group Incorporated
  Registration Statement on Form S-4
Filed  February 21, 2017
  File No.  333-216153

Dear Ms. Short :

We have limited our review of your registration statement to those issues we have
addressed in our comment .

Please respond to this letter by amending your registration statement and providing the
requested information .  If you do not believe our comment  applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.

After reviewing any amendment to your registration statement and the information you
provide in  response to this comment , we may have  additional comments.

General

1. We note that your filing incorporates by reference the Annual Report on Form 10 -K for
the fiscal year ended December 31, 2016. We also note that Part III of the Form 10 -K
incorporate s by reference the proxy statement for the 2017 annual meeting of
shareholders, which has not yet been filed. Please be advised that we will not be in a
position to accelerate the effective date of your registration statement until the 10 -K is
amended to include Part II I information, or the proxy statement is filed . For guidance,
please refer generally to an analogous provision applicable to Form S -3 registrant s in
Securities Act Forms Compliance and Disclosure Interpretation 123.01.

We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or a bsence of
action by the staff.

Marianne D. Short
UnitedHealth Group Incorporated
February 28, 2017
Page 2

Refer to Rules 460 and 461 regarding requests for  acceleration .  Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.

You may contact Chris Edwards at (202) 551 -6761 or Mary Beth Breslin at (202) 551 -
3625 with any questions.

Sincerely,

 /s/ Mary Beth Breslin for

 Suzanne Hayes
Assistant Director
Office of Healthcare and Insurance

cc: David R. Crandall, Esq.
Hogan Lovells US LLP